Aperçu rapide pour Fas Ligand Inhibitor Peptide (ABIN925004)
Antigène
Fas Ligand Inhibitor
Origine
Humain, Souris, Rat
Application
Functional Studies (Func)
Specificité
Inhibits the apoptosis-inducing activity of Fas Ligand. Binds FasL (APO-1L, CD95L, CD178).
Attributs du produit
Extracellular domain of human Fas (aa. 7-154) fused to Fc portion of human IgG1.
Pureté
95 % as determined by SDS-PAGE
niveau d'endotoxine
<0.1 EU/µg purified protein as determined by LAL test.
Indications d'application
Functional Application: Inhibition of FAS Ligand activity in human and mouse: The apoptosis-inducing activity of FasL is inhibited by concentrations of 20-100 µg/mL of the fusion protein. Concentrations of Fas Ligand Inhibitor required to inhibit may vary depending on the cell viability and on the concentrations of sFasL used to kill the cells.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Reconstitute with 50 µL sterile water to produce a 1 mg/mL solution in PBS. Further dilutions should be made with medium containing 5% fetal calf serum (FCS) or a carrier protein.
Buffer
PBS
Stock
-20 °C
Antigène
Fas Ligand Inhibitor
Sujet
Fas is a 45 kDa type I transmembrane protein belonging to the TNF receptor family. Fas contains 3 cysteine-rich repeats in the extracellular portion and a cytoplasmic motif called the `death domain' (DD). Death signals are triggered upon binding to its trimeric ligand FasL which induces oligomerization of Fas. The DD associates with FADD, which in turn connects to aspartate-specific proteases (caspases) that are implicated as mediators of most types of apoptotic cell death. Synonyms: APO-1, CD95, TNFRSF 6